Vancouver, British Columbia — February 20, 2026 — Leads & Copy — Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) announced that shareholders approved all meeting matters at its 2026 special meeting of shareholders held on February 20, 2026.
Shareholders approved resolutions related to the company’s private placement of convertible debentures and the amendment to the expiry date of its outstanding warrants held by insiders. Disinterested shareholder approval was obtained in connection with certain resolutions.
The company expects to close the Convertible Debenture Financing on or about February 24, 2026.
Burcon has filed a report of voting results setting out the full details of the voting results for each resolution passed at the Meeting on the SEDAR+ website.
Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Its commercial ingredients offer taste, texture, and functionality for formulators seeking next-generation protein solutions. The company holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources.
Source: Burcon NutraScience Corporation
